Trial intelligence / Profile preview

Lidocaine vs Dexmedetomidine vs Combination for Perioperative Pain in VATS

NCT06837519Completed

Sponsor
Ain Shams University
Start
Feb 2025
Primary completion
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in perioperative pain comparing Lidocaine group, Dexmedetomidine group and Lidocaine and Dexmedetomidine group (3 arms). Primary endpoint: Total morphine consumption. Started Feb 2025; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrinedexmedetomidine
03

Conditions

perioperative pain

Beyond the preview

Go deeper on NCT06837519.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06837519.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call